Vaccination

Addressing HPV vaccination concerns

Research from the Harvard Pilgrim Health Care Institute finds a promising avenue for addressing vaccine hesitancy around HPV vaccine. The study, "Tailored Messages Addressing HPV Vaccination Concerns Improves Behavioral Intent ...

HIV & AIDS

The search for an effective HIV vaccine continues

An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was ...

Diseases, Conditions, Syndromes

Recent advances in addressing tuberculosis give hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the ...

Diseases, Conditions, Syndromes

Experimental HIV vaccine regimen ineffective in preventing HIV

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine. This ...

Diseases, Conditions, Syndromes

New therapeutic approach may help to cure chronic hepatitis B infection

Researchers at Helmholtz Zentrum M√ľnchen, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. The scientists found ...

Oncology & Cancer

Can the flu shot help fight cancer?

Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies. The ...

page 2 from 17